Sign up for the QMED & MD+DI Daily newsletter.
Preparing for Mergers and Acquisitions
March 1, 2004
1 Min Read
Originally Published MX March/April 2004
BUSINESS PLANNING & TECHNOLOGY DEVELOPMENT
Large medtech companies may be eager for corporate matrimony, but buyers and sellers still have a lot to consider before tying the knot.
For the past few years, the anemic condition of the global economy and correspondingly weak public equity markets have combined to restrain investment in medical technology companies. For many medtech companies seeking to pay off investors, the only viable exit strategy has been to seek out a merger or agree to be acquired--and hope that favorable terms could be found.
Today, with the U.S. economy seemingly on its way to recovery, the pace of mergers and acquisitions among medtech companies is showing signs of even greater favor. Large-company acquirers are actively on the lookout for emerging companies whose technologies could represent a breakthrough or key product-line extension. Meanwhile target companies are eagerly grooming themselves for sale at a valuation that might finally provide their early-stage investors with a reasonable return on investment.
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read